Loco: Based on the events of the last couple of months why do I still have faith in Gerald? Good question!
In 2014 things really haven't gone the way Gerald said they would....and yet they kind of have. There have definitely been delays: Toxicology Report? Up listing in the First Half of 2014? LymPro data at the two July Conferences? etc. So yes, things haven't gone quite the way Gerald said they would.
And yet, they have. He hasn't abandoned any of his milestones, he has just reshuffled them to meet changing variables that are always being thrown at him. The LymPro science is better than we expected. (Version 2 even better than version 1) Gerald will have a LymPro partner soon and commercialization by year end. He has advanced the MANF indications Retinitis and Wolframs/Diabetes in particular. Within weeks we will receive astonishing data and probably hear of orphan designations. Gerald told me in Santa Monica that once orphaned, those indications would become very "partnerable."
So yes, I was disappointed to not get the complete data I was expecting at either of the two July Conferences. And yes, Gerald could have managed expectations better. But, it's not like he has ruined LymPro or MANF, he has enhanced them! He is doing what he believes is best for their advancement. He has secured financing from Lincoln Park Capital and is gaining momentum with the scientific community with everything he is involved in.
I think the relationship he has forged with Cavendish will become a major score. A rumor I've heard, but can't substantiate, is that they might use their money and influence to help launch LymPro!! When LymPro is ready in November can you imagine the possibilities Gerald has to get in front of the media and encourage everyone that is dealing with Alzheimer's to come in and get checked? He'll definitely be in the media doing interviews on 60 minutes and the like. But maybe an ally like Cavendish, with all their family offices and influence and money, might assist us to make Lympro become the industry standard even quicker?
Just because we didn't get the data we expected at the two conferences doesn't justify losing faith in Gerald. I have met him personally three times. I have asked him question after question after question (as I am prone to do) and he politely and straightforwardly dealt with each of them. (The best he could without revealing insider information) If Gerald were a flim flam man I would have spotted it. I'm really good at reading people. If I had picked up on any of that, I never would have invested as heavily in AMBS.
Back in September in 2013 right after I took a small position in AMBS Gerald had a Conference scheduled in Las Vegas, a few hours drive from our home in Southern California. A friend of mine who had already taken a major position in AMBS was trying to persuade me to go in deeper. So my wife and I decided to go meet and talk with Gerald before we took the plunge. We spoke to him for over an hour. On the car ride home, we were trying to figure out how to move as much of our investments and cash into AMBS as we possibly could.
Gerald is the real deal and so is AMBS. And so is the incredible team he has assembled. This is why I still have faith in him. In the end, it all boils down to doing what you believe in.
In 2014 things really haven't gone the way Gerald said they would....and yet they kind of have. There have definitely been delays: Toxicology Report? Up listing in the First Half of 2014? LymPro data at the two July Conferences? etc. So yes, things haven't gone quite the way Gerald said they would.
And yet, they have. He hasn't abandoned any of his milestones, he has just reshuffled them to meet changing variables that are always being thrown at him. The LymPro science is better than we expected. (Version 2 even better than version 1) Gerald will have a LymPro partner soon and commercialization by year end. He has advanced the MANF indications Retinitis and Wolframs/Diabetes in particular. Within weeks we will receive astonishing data and probably hear of orphan designations. Gerald told me in Santa Monica that once orphaned, those indications would become very "partnerable."
So yes, I was disappointed to not get the complete data I was expecting at either of the two July Conferences. And yes, Gerald could have managed expectations better. But, it's not like he has ruined LymPro or MANF, he has enhanced them! He is doing what he believes is best for their advancement. He has secured financing from Lincoln Park Capital and is gaining momentum with the scientific community with everything he is involved in.
I think the relationship he has forged with Cavendish will become a major score. A rumor I've heard, but can't substantiate, is that they might use their money and influence to help launch LymPro!! When LymPro is ready in November can you imagine the possibilities Gerald has to get in front of the media and encourage everyone that is dealing with Alzheimer's to come in and get checked? He'll definitely be in the media doing interviews on 60 minutes and the like. But maybe an ally like Cavendish, with all their family offices and influence and money, might assist us to make Lympro become the industry standard even quicker?
Just because we didn't get the data we expected at the two conferences doesn't justify losing faith in Gerald. I have met him personally three times. I have asked him question after question after question (as I am prone to do) and he politely and straightforwardly dealt with each of them. (The best he could without revealing insider information) If Gerald were a flim flam man I would have spotted it. I'm really good at reading people. If I had picked up on any of that, I never would have invested as heavily in AMBS.
Back in September in 2013 right after I took a small position in AMBS Gerald had a Conference scheduled in Las Vegas, a few hours drive from our home in Southern California. A friend of mine who had already taken a major position in AMBS was trying to persuade me to go in deeper. So my wife and I decided to go meet and talk with Gerald before we took the plunge. We spoke to him for over an hour. On the car ride home, we were trying to figure out how to move as much of our investments and cash into AMBS as we possibly could.
Gerald is the real deal and so is AMBS. And so is the incredible team he has assembled. This is why I still have faith in him. In the end, it all boils down to doing what you believe in.
